<DOC>
	<DOCNO>NCT02043769</DOCNO>
	<brief_summary>The Pediatric Enhanced Surveillance Study three part study HIV-infected infant child South Africa examine , clinical , immunologic , virologic , metabolic , psychosocial behavioral outcome . This study two part : ( 1 ) comprehensive de-identiﬁed record review HIV-infected child enrol pediatric Wellness ART clinic ﬁve study site ; ( 2 ) prospective cohort surveillance study active consent enrollment 12-24 month follow-up . As part prospective cohort , study aim collect outcomes child lose follow-up , include cause death review death certiﬁcates clinical chart verbal autopsy report . The study provide insight overall outcomes large pediatric patient population province South Africa . This work design collaboration provincial health authority Eastern Cape Department Health ( EC ) , The International Center acquire immune deficiency syndrome ( AIDS ) Care Treatment Programs ( ICAP ) South Africa Center Disease Control ( CDC ) -South Africa support South African National ART Program Children aim collect analyze accurate , relevant useful information available child see facility . For prospective cohort study , aim enroll 400 child newly initiate ART 5 health facility Eastern Cape South Africa actively follow 24 month .</brief_summary>
	<brief_title>Pediatric Enhanced Surveillance Study</brief_title>
	<detailed_description>South Africa one country hard hit HIV/AIDS epidemic . There 5 million people live HIV South Africa , include 280,000 child age 15 . Most HIV positive child acquire infection mother-to-child transmission ; South Africa 29.3 % pregnant woman attend antenatal service HIV-infected . Furthermore , estimate HIV cause 35 % deaths child five South Africa . The South African government begin national rollout HIV treatment adult child 2003 . As 2007 , estimate 32,060 child age 15 receive antiretroviral therapy ( roughly 30 % need ) . There urgent need obtain comprehensive , in-depth , profile child enrol HIV care focus document outcome , particularly time cause death , reason loss follow-up , time frequency treatment failure , adverse event , metabolic complication psychosocial aspect HIV disease .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>The child eligible antiretroviral therapy ( ART ) initiation base South African Pediatric HIV guideline . The child documentation HIVinfected positive HIVDeoxyribonucleic acid ( DNA ) polymerase chain reaction ( PCR ) , detectable HIV ribonucleic acid ( RNA ) viral load positive HIV antibody test ( &gt; 18 month age ) . The child prior history treatment ART prophylaxis prevent mother child transmission ( PMTCT ) ( may initiate ART day enrollment study ) . The child 1 month 12 year age . The parent legal guardian provide write consent participation . The child provide assent participation base South African guidance minor . Any subject meeting inclusion criterion eligible study .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>South Africa</keyword>
	<keyword>Eastern Cape</keyword>
	<keyword>Child ARV</keyword>
	<keyword>CLWHIV</keyword>
</DOC>